Glp-1 Receptor Agonists And Left Ventricular Function
Comprehensive Insights and Gallery of Glp-1 Receptor Agonists And Left Ventricular Function
The Effects of GLP
Cardiac function outcomes, such as left ventricular ejection fraction and myocardial strain metrics, were largely unchanged, particularly in patients with T2DM. GLP-1 receptor agonists were associated with increased myocardial perfusion and decreased NT-proBNP and C-reactive protein (CRP), suggesting cardioprotective effects.
Glp-1 Receptor Agonists And Left Ventricular Function
Pharmacological activation the GLP-1 receptor may preserve left ventricular diastolic function . Their efficacy unlikely depends on drug class or the presence of obesity but may vary among etiologies of cardiac disorders.
Glp-1 Receptor Agonists And Left Ventricular Function
Effects of GLP
Glp-1 Receptor Agonists And Left Ventricular Function
Effects of the novel long-acting GLP-1 agonist , albiglutide, on cardiac function , cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction.
Wong SY, Bin Lee ARY, Sia AHJ, et al. Effects of Glucagon-Like Peptide-1 Receptor Agonist ( GLP -1RA) on Cardiac Structure and Function : A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) have demonstrated significant cardiovascular (CV) benefits, particularly in patients with diabetes mellitus, but the safety and efficacy of different GLP-1 RAs across diverse populations remain insufficiently defined.